News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
2,962 Results
Type
Article (27)
Press Release (2935)
Section
Business (1334)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2104)
Policy (116)
Tag
Academia (3)
Alliances (42)
Alzheimer's disease (27)
Approvals (104)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (297)
Breast cancer (4)
Cancer (44)
Career advice (1)
Clinical research (617)
Collaboration (4)
Compensation (1)
COVID-19 (4)
Data (55)
Diabetes (1)
Diagnostics (20)
Earnings (1365)
Events (321)
FDA (116)
Frontotemporal dementia (1)
Funding (2)
Generative AI (1)
Gene therapy (4)
GLP-1 (7)
Government (8)
Healthcare (85)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (160)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (19)
Lymphoma (6)
Manufacturing (1)
MASH (3)
Medical device (56)
Medtech (56)
Mergers & acquisitions (23)
Metabolic disorders (5)
Multiple sclerosis (2)
NASH (1)
Neuroscience (33)
NextGen: Class of 2025 (9)
Non-profit (4)
Northern California (25)
Obesity (1)
Parkinson's disease (1)
People (8)
Phase I (94)
Phase II (187)
Phase III (363)
Pipeline (28)
Postmarket research (27)
Preclinical (11)
Prostate cancer (2)
Radiopharmaceuticals (6)
Rare diseases (4)
Regulatory (136)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Schizophrenia (2)
Southern California (9)
Startups (3)
United States (201)
Vaccines (3)
Date
Today (3)
Last 7 days (11)
Last 30 days (34)
Last 365 days (421)
2025 (45)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (327)
Australia (13)
California (36)
Canada (12)
China (6)
Delaware (11)
Europe (586)
Florida (5)
Georgia (2)
Illinois (4)
Indiana (16)
Japan (7)
Maryland (7)
Massachusetts (29)
Minnesota (1)
New Jersey (35)
New York (24)
North Carolina (7)
Northern California (25)
Ohio (2)
Pennsylvania (16)
South America (5)
Southern California (9)
Texas (4)
Utah (4)
Washington State (2)
2,962 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Piramal Pharma Limited Announces Results for Q3 and 9M FY25
January 29, 2025
·
6 min read
Press Releases
New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer
February 17, 2025
·
9 min read
Press Releases
Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Switzerland for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
February 18, 2025
·
7 min read
Press Releases
Aldeyra Therapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
February 4, 2025
·
1 min read
Press Releases
Devonian Reports Positive Results in MASH Liver Study
February 14, 2025
·
8 min read
Press Releases
GUERBET : 2024 revenue.
February 7, 2025
·
8 min read
Press Releases
PENMENVY, GSK’s 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY
February 17, 2025
·
13 min read
Press Releases
Regeneron Reports Fourth Quarter and Full Year 2024 Financial and Operating Results; Initiates Quarterly Dividend and Increases Total Share Repurchase Capacity to ~$4.5 Billion
February 5, 2025
·
35 min read
Press Releases
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
February 21, 2025
·
10 min read
Press Releases
ICON Reports Fourth Quarter and Full Year 2024 Results
February 19, 2025
·
16 min read
1 of 297
Next
